{
    "organizations": [],
    "uuid": "5cecdeb7668627e90079fc0006ff15f44e305a14",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-otonomy-announces-fda-approval-of/brief-otonomy-announces-fda-approval-of-otiprio-for-acute-otitis-externa-idUSASB0C8N3",
    "ord_in_thread": 0,
    "title": "BRIEF-Otonomy Announces FDA Approval Of Otiprio For Acute Otitis Externa",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "  BRIEF-Otonomy Announces FDA Approval Of Otiprio For Acute Otitis Externa Reuters Staff March 2 (Reuters) - Otonomy Inc: * OTONOMY ANNOUNCES FDA APPROVAL OF OTIPRIO(R) FOR ACUTE OTITIS EXTERNA * FDA APPROVED OTIPRIO FOR TREATING ACUTE OTITIS EXTERNA IN PATIENTS 6 MONTHS & OLDER DUE TO PSEUDOMONAS AERUGINOSA & STAPHYLOCOCCUS AUREUS Source text for Eikon: Further company coverage:",
    "published": "2018-03-03T00:59:00.000+02:00",
    "crawled": "2018-03-02T19:09:00.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "announces",
        "fda",
        "approval",
        "otiprio",
        "acute",
        "otitis",
        "externa",
        "reuters",
        "staff",
        "march",
        "reuters",
        "otonomy",
        "inc",
        "otonomy",
        "announces",
        "fda",
        "approval",
        "otiprio",
        "r",
        "acute",
        "otitis",
        "externa",
        "fda",
        "approved",
        "otiprio",
        "treating",
        "acute",
        "otitis",
        "externa",
        "patient",
        "month",
        "older",
        "due",
        "pseudomonas",
        "aeruginosa",
        "staphylococcus",
        "aureus",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}